Cargando…
Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Japanese Respiratory Society. Published by Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539801/ https://www.ncbi.nlm.nih.gov/pubmed/33067149 http://dx.doi.org/10.1016/j.resinv.2020.09.006 |
| _version_ | 1783591100180594688 |
|---|---|
| author | Nakamura, Hideta Miyagi, Kazuya Otsuki, Mariko Higure, Yuuri Nishiyama, Naoya Kinjo, Takeshi Nakamatsu, Masashi Haranaga, Shusaku Tateyama, Masao Fujita, Jiro |
| author_facet | Nakamura, Hideta Miyagi, Kazuya Otsuki, Mariko Higure, Yuuri Nishiyama, Naoya Kinjo, Takeshi Nakamatsu, Masashi Haranaga, Shusaku Tateyama, Masao Fujita, Jiro |
| author_sort | Nakamura, Hideta |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7539801 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | The Japanese Respiratory Society. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75398012020-10-08 Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series Nakamura, Hideta Miyagi, Kazuya Otsuki, Mariko Higure, Yuuri Nishiyama, Naoya Kinjo, Takeshi Nakamatsu, Masashi Haranaga, Shusaku Tateyama, Masao Fujita, Jiro Respir Investig Letter to the Editor The Japanese Respiratory Society. Published by Elsevier B.V. 2020-11 2020-10-07 /pmc/articles/PMC7539801/ /pubmed/33067149 http://dx.doi.org/10.1016/j.resinv.2020.09.006 Text en © 2020 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Nakamura, Hideta Miyagi, Kazuya Otsuki, Mariko Higure, Yuuri Nishiyama, Naoya Kinjo, Takeshi Nakamatsu, Masashi Haranaga, Shusaku Tateyama, Masao Fujita, Jiro Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series |
| title | Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series |
| title_full | Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series |
| title_fullStr | Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series |
| title_full_unstemmed | Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series |
| title_short | Use of the interleukin 6 inhibitor tocilizumab in Japanese patients with cytokine release syndrome caused by COVID-19-related acute respiratory distress syndrome: A case series |
| title_sort | use of the interleukin 6 inhibitor tocilizumab in japanese patients with cytokine release syndrome caused by covid-19-related acute respiratory distress syndrome: a case series |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539801/ https://www.ncbi.nlm.nih.gov/pubmed/33067149 http://dx.doi.org/10.1016/j.resinv.2020.09.006 |
| work_keys_str_mv | AT nakamurahideta useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT miyagikazuya useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT otsukimariko useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT higureyuuri useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT nishiyamanaoya useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT kinjotakeshi useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT nakamatsumasashi useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT haranagashusaku useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT tateyamamasao useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries AT fujitajiro useoftheinterleukin6inhibitortocilizumabinjapanesepatientswithcytokinereleasesyndromecausedbycovid19relatedacuterespiratorydistresssyndromeacaseseries |